Table 1.
Baseline patient characteristics.
| Studies | Arms | N = 3172 | Mean age (year) | Men (%) | HTN (%) | DM (%) | Smoking (%) | Prior MI (%) | Follow up (months) |
|---|---|---|---|---|---|---|---|---|---|
| DANAMI-3-PRIMULTI [11] | CR-S | 314 | 64 | 80 | 41 | 9 | 51 | 5 | 27 |
| IRA | 313 | 63 | 81 | 47 | 13 | 48 | 9 | ||
| POLITI et al. [25] | IRA | 84 | 67 | 76 | 60 | 24 | N/A | N/A | 29 |
| CR-S | 65 | 64 | 80 | 65 | 19 | N/A | N/A | ||
| CR-I | 65 | 65 | 77 | 49 | 14 | N/A | N/A | ||
| CvLPRIT [10] | IRA | 146 | 65 | 77 | 36 | 14 | 27 | 3.6 | 12 |
| CR (CR-I 64.6%; CR-S 35.4%) | 150 | 65 | 85 | 37 | 13 | 34 | 4.8 | ||
| PRAMI [9] | CR -I | 234 | 62 | 76 | 40 | 15 | 50 | 8 | 23 |
| IRA | 231 | 62 | 81 | 40 | 21 | 45 | 7 | ||
| HAMZA et al.[12] | IRA | 50 | 52 | 86 | 36 | 100 | 78 | 6 | 6 |
| CR (58% CR-I;42% CR-S) | 50 | 56 | 82 | 26 | 100 | 72 | 10 | ||
| PRAGUE-13 [23] | CR-S | 106 | NA | NA | NA | NA | NA | NA | 38 |
| IRA | 108 | NA | NA | NA | NA | NA | NA | ||
| HELP-AMI [44] | IRA | 17 | 65 | 85 | 59 | 41 | 81 | 12 | |
| CR-I | 52 | 64 | 88 | 37 | 12 | 67 | |||
| GHANI et al. [43] | CR-S | 80 | 62 | 80 | 26 | 6 | 44 | 6 | 36 |
| IRA | 41 | 61 | 81 | 43 | 5 | 48 | 5 | ||
| TARASOV et al. [42] | CR-I | 46 | 59 | 70 | 96 | 26 | 0 | 11 | 6 |
| CR-S | 43 | 59 | 58 | 86 | 21 | 0 | 5 | ||
| PRIMA [24] | CR-I | 48 | 65 | 73 | 52 | 31 | 38 | 29 | 6 |
| CR-S | 44 | 67 | 75 | 48 | 34 | 43 | 23 | ||
| COMPARE ACUTE [13] | CR (83.4% CR-I;16.6%CR-S) | 295 | 62 | 79 | 46 | 15 | 41 | 8 | 12 |
| IRA | 590 | 61 | 76 | 48 | 16 | 49 | 8 | ||
CR-S = complete revascularization staged, CR-I = complete revascularization instant, IRA = infarctrelated artery, CR = complete revascularization, N/A = not available. HTN = hypertension, DM = diabetes mellitus, MI = myocardial infarction.